Help Desk
10 Am-7 Pm (Mon-Sat)
Contact
+91 728 787 4503
cancermeds-list
cancermeds-noimage

TABI TABLET ( STRIP , 10 )

Manufactured by : Dr. Reddy’s Laboratories Ltd

. 360.80 .439.50 17.90 % OFF You Save : .78.70
Availability : In stock

DESCRIPTION

Bicalutamide is an oral non-steroidal anti-androgen for prostate cancer. It binds to the androgen receptor.

CATEGORIES

Antineoplastic and Immunomodulating Agents Endocrine Therapy Hormone Antagonists and Related Agents Anti-Androgens Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inducers Cytochrome P-450 CYP2C19 Inducers CYP2D6 Inducers CYP2D6 Inducers (strong) CYP3A4 Inhibitors

CHEMICAL FORMULA

C18H14F4N2O4S

COMPOSITION

Bicalutamide 50 MG

INDICATION

For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer.

PHARMACODYNAMICS

Bicalutamide is an antineoplastic hormonal agent primarily used in the treatment of prostate cancer. Bicalutamide is a pure, nonsteroidal anti-androgen with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors). Consequently, Bicalutamide blocks the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue. Prostate cancer is mostly androgen-dependent and can be treated with surgical or chemical castration. To date, antiandrogen monotherapy has not consistently been shown to be equivalent to castration.

MECHANISM

Bicalutamide competes with androgen for the binding of androgen receptors, consequently blocking the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue.

ABSORPTION

Bicalutamide is well-absorbed following oral administration, although the absolute bioavailability is unknown.

METABOLISM

Bicalutamide undergoes stereo specific metabolism. The S (inactive) isomer is metabolized primarily by glucuronidation. The R (active) isomer also undergoes glucuronidation but is predominantly oxidized to an inactive metabolite followed by glucuronidation.

HALF LIFE

5.9 days

FOOD INTERACTIONS

Take without regard to meals, at the same time everyday.

SIDE EFFECTS

Nausea, vomiting, diarrhoea, asthenia, gynaecomastia, breast tenderness, hot flushes, pruritus, dry skin, alopecia, hirsutism, decreased libido, impotence, weight gain; less commonly hypersensitivity reactions including angioneurotic oedema and urticaria, interstitial lung disease; rarely abdominal pain, CV disorders (including angina, heart failure and arrhythmias), depression, dyspepsia, haematuria, cholestasis, jaundice, thrombocytopenia.